Table of Contents Author Guidelines Submit a Manuscript
Interdisciplinary Perspectives on Infectious Diseases
Volume 2012 (2012), Article ID 980739, 8 pages
http://dx.doi.org/10.1155/2012/980739
Review Article

Cardiac Autonomic Control Mechanisms in the Pathogenesis of Chagas' Heart Disease

Instituto de Investigaciones Cardiovasculares, Departamento de Fisiopatología, Instituto de Inmunologìa Clinica, Facultad de Medicina, Hospital Universitario de Los Andes, Universidad de Los Andes, Mérida 5101, Venezuela

Received 1 June 2012; Accepted 27 August 2012

Academic Editor: Decio Diament

Copyright © 2012 Diego F. Dávila et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Marin-Neto, E. Cunha-Neto, B. C. Maciel, and M. V. Simões, “Pathogenesis of chronic Chagas heart disease,” Circulation, vol. 115, no. 9, pp. 1109–1123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. Macedo, C. R. Machado, R. P. Oliveira, and S. D. J. Pena, “Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease,” Memorias do Instituto Oswaldo Cruz, vol. 99, no. 1, pp. 1–12, 2004. View at Google Scholar · View at Scopus
  3. D. F. Dávila, J. H. Donis, A. Torres, and J. A. Ferrer, “A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease,” International Journal of Cardiology, vol. 96, no. 2, pp. 191–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Rassi Jr, A. Rassi, and S. G. Rassi, “Predictors of mortality in chronic Chagas disease: a systematic review of observational studies,” Circulation, vol. 115, no. 9, pp. 1101–1108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Koberle, “Cardiopatia parasympathicopriva,” Munchener Medizinische Wochenschrift, pp. 1308–1310, 1959. View at Google Scholar
  6. F. Koberle, “Pathogenesis of Chagas' disease,” Ciba Foundation Symposium, vol. 20, pp. 137–152, 1974. View at Google Scholar
  7. D. Iosa, V. DeQuattro, D. D. P. Lee, U. Elkayam, and H. Palmero, “Plasma norepinephrine in Chagas' cardioneuromyopathy: a marker of progressive dysautonomia,” American Heart Journal, vol. 117, no. 4, pp. 882–887, 1989. View at Google Scholar · View at Scopus
  8. D. Iosa, V. Dequattro, D. D. P. Lee, U. Elkayam, T. Caeiro, and H. Palmero, “Pathogenesis of cardiac neuro-myopathy in Chagas' disease and the role of the autonomic nervous system,” Journal of the Autonomic Nervous System, vol. 30, pp. S83–S87, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Goin, E. Borda, C. P. Leiros, R. Storino, and L. Sterin-Borda, “Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications,” Journal of the Autonomic Nervous System, vol. 47, no. 1-2, pp. 45–52, 1994. View at Google Scholar · View at Scopus
  10. D. F. Davila, F. Roveda, H. R. Middlekauff, and C. E. Negrao, “Sympathetic nervous system activation in chagasic patients with congestive heart failure [2] (multiple letters),” Journal of the American College of Cardiology, vol. 43, no. 9, pp. 1723–1724, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. D. F. Dávila, J. H. Donis, A. Torres, C. F. Gottberg, P. Ramoni-Perazzi, and G. Arata de Bellabarba, “Beta-adrenergic blockers in chronic systolic heart failure secondary to Chagas' disease,” International Journal of Cardiology, vol. 128, no. 1, pp. 1–4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Das neves, M. L. Bacilio, L. Berrueta et al., “Muscarinic antibodies and heart rate responses to dynamic exercise and to the valsalva maneuver in chronic chagasic patients,” Revista do Instituto de Medicina Tropical de Sao Paulo. In press.
  13. J. S. M. Oliveira, “A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy,” American Heart Journal, vol. 110, no. 5, pp. 1092–1098, 1985. View at Google Scholar · View at Scopus
  14. D. S. Amorim, J. C. Manco, L. Gallo, and J. A. Marin Neto, “Chagas' heart disease as an experimental model for studies of cardiac autonomic function in man,” Mayo Clinic Proceedings, vol. 57, no. 1, pp. 48–60, 1982. View at Google Scholar · View at Scopus
  15. D. F. Davila, R. O. Rossell, and J. H. Donis, “Cardiac parasympathetic abnormalities: cause or consequence of Chagas heart disease?” Parasitology Today, vol. 5, no. 10, pp. 327–329, 1989. View at Google Scholar · View at Scopus
  16. C. F. Gottberg, J. H. Donis, A. Torres, A. J. Fuenmayor, and D. F. Davila, “Heart rate changes in rats with acute Chagasic myocarditis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 82, no. 6, p. 851, 1988. View at Google Scholar · View at Scopus
  17. D. F. Davila, C. F. Gottberg, J. H. Donis, A. Torres, A. J. Fuenmayor, and O. Rossell, “Vagal stimulation and heart rate slowing in acute experimental chagasic myocarditis,” Journal of the Autonomic Nervous System, vol. 25, no. 2-3, pp. 233–234, 1988. View at Google Scholar · View at Scopus
  18. D. F. Davila, C. F. Gottberg, A. Torres et al., “Cardiac sympathetic-parasympathetic balance in rats with experimentally-induced acute chagasic myocarditis,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 37, no. 2, pp. 155–159, 1995. View at Google Scholar · View at Scopus
  19. A. Torres, D. F. Davila, C. F. Gottberg et al., “Heart rate responses to intravenous serotonin in rats with acute chagasic myocarditis,” Brazilian Journal of Medical and Biological Research, vol. 29, no. 6, pp. 817–822, 1996. View at Google Scholar · View at Scopus
  20. A. Torres, D. F. Dávila, C. F. Gottberg, J. H. Donis, G. Arata De Bellabarbaba, and P. Ramoni-Perazzi, “Heart rate responses to a muscarinic agonist in rats with experimentally induced acute and subacute chagasic myocarditis,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 42, no. 4, pp. 219–224, 2000. View at Google Scholar · View at Scopus
  21. A. Ollarves, D. F. Dávila, C. F. Gottberg, and P. Ramoni-Perazzi, “Serial heart rate changes in rats inoculated by conjunctival instillation of Trypanosoma cruzi obtained from bug faeces.,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 33, no. 6, pp. 529–533, 2000. View at Google Scholar · View at Scopus
  22. D. F. Davila, J. H. Donis, M. Navas, A. J. Fuenmayor, A. Torres, and C. Gottberg, “Response of heart rate to atropine and left ventricular function in Chagas' heart disease,” International Journal of Cardiology, vol. 21, no. 2, pp. 143–152, 1988. View at Google Scholar · View at Scopus
  23. A. J. Fuenmayor, L. Rodriguez, A. Torres et al., “Valsalva maneuver: a test of the functional state of cardiac innervation in Chagasic myocarditis,” International Journal of Cardiology, vol. 18, no. 3, pp. 351–356, 1988. View at Google Scholar · View at Scopus
  24. R. O. Odreman, D. F. Dávila, J. H. Donis, A. Torres, J. Ferrer, and I. Inglessis, “Valsalva maneuver in chagasic patients with documented past medical history of acute chagasic myocarditis,” International Journal of Cardiology, vol. 93, no. 2-3, pp. 163–167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. D. F. Davila, J. H. Donis, A. Torres, C. F. Gottberg, and O. Rossell, “Cardiac parasympathetic innervation in Chagas' heart disease,” Medical Hypotheses, vol. 35, no. 2, pp. 80–84, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. D. F. Davila, G. Bellabarbra, J. H. Donis et al., “Cardiac autonomic control mechanisms in Chagas' heart disease. Therapeutic implications,” Medical Hypotheses, vol. 40, no. 1, pp. 33–37, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Sterin-Borda and E. Borda, “Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia,” Annals of the New York Academy of Sciences, vol. 917, pp. 273–280, 2000. View at Google Scholar · View at Scopus
  28. P. Harris, “Evolution and the cardiac patient,” Cardiovascular Research, vol. 17, no. 8, pp. 248–254, 1983. View at Google Scholar
  29. P. F. Binkley, E. Nunziata, G. J. Haas, S. D. Nelson, and R. J. Cody, “Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure,” Journal of the American College of Cardiology, vol. 18, no. 2, pp. 464–472, 1991. View at Google Scholar · View at Scopus
  30. T. R. Porter, D. L. Eckberg, J. M. Fritsch et al., “Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations,” Journal of Clinical Investigation, vol. 85, no. 5, pp. 1362–1371, 1990. View at Google Scholar · View at Scopus
  31. G. M. Eaton, R. J. Cody, E. Nunziata, and P. F. Binkley, “Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure,” Circulation, vol. 92, no. 3, pp. 555–561, 1995. View at Google Scholar · View at Scopus
  32. D. F. Davila, G. Bellabarba, L. Hernández et al., “Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagas' heart disease,” International Journal of Cardiology, vol. 24, no. 2, pp. 145–151, 1995. View at Google Scholar
  33. R. B. Bestetti, J. Coutinho-Netto, L. Staibano, L. Z. Pinto, G. Muccillo, and J. S. M. Oliveira, “Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease,” Cardiology, vol. 86, no. 3, pp. 202–206, 1995. View at Google Scholar · View at Scopus
  34. R. L. Tarleton, “Parasite persistence in the aetiology of Chagas disease,” International Journal for Parasitology, vol. 31, no. 5-6, pp. 550–554, 2001. View at Google Scholar · View at Scopus
  35. N. Añez, H. Carrasco, H. Parada et al., “Myocardial parasite persistence in chronic chagasic patients,” American Journal of Tropical Medicine and Hygiene, vol. 60, no. 5, pp. 726–732, 1999. View at Google Scholar · View at Scopus
  36. A. M. Khoury, D. F. Davila, G. Bellabarba et al., “Acute effects of digitalis and enalapril on the neurohormonal profile of chagasic patients with severe congestive heart failure,” International Journal of Cardiology, vol. 57, no. 1, pp. 21–29, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Bellabarba, D. F. Davila, A. Torres et al., “Plasma renin activity in chagasic patients with and without congestive heart failure,” International Journal of Cardiology, vol. 47, no. 1, pp. 5–11, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. C. E. Negrão, A. C. Santos, M. U. Rondon et al., “Muscle sympathetic nerve activity in patients with Chagas' disease,” International Journal of Cardiology, vol. 137, no. 3, pp. 252–259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. H. A. Carrasco, H. Parada, L. Guerrero, M. Duque, D. Durán, and C. Molina, “Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease,” International Journal of Cardiology, vol. 43, no. 1, pp. 27–38, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. D. F. Dávila, F. Angel, G. Arata de Bellabarba, and J. H. Donis, “Effects of metoprolol in chagasic patients with severe congestive heart failure,” International Journal of Cardiology, vol. 85, no. 2-3, pp. 255–260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. H. A. Luquez, R. Madoery, S. R. Amuchastegui, and J. A. Patrignani, “Symptomatic management of Chagas' heart disease using a beta-adrenergic blocking agent,” Prensa Medica Argentina, vol. 55, no. 17, pp. 774–778, 1968. View at Google Scholar · View at Scopus
  42. F. A. Botoni, P. A. Poole-Wilson, A. L. P. Ribeiro et al., “A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy,” American Heart Journal, vol. 153, no. 4, pp. 544–e1, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. T. A. D. Theodoropoulos, R. B. Bestetti, A. P. Otaviano, J. A. Cordeiro, V. C. Rodrigues, and A. C. Silva, “Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy,” International Journal of Cardiology, vol. 128, no. 1, pp. 22–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. V. S. Issa, A. F. Amaral, F. D. Cruz et al., “β-Blocker therapy and mortality of patients with Chagas cardiomyopathy a subanalysis of the REMADHE prospective trial,” Circulation, vol. 3, no. 1, pp. 82–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. R. B. Bestetti, A. P. Otaviano, A. Cardinalli-Neto, B. F. da Rocha, T. A. D. Theodoropoulos, and J. A. Cordeiro, “Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure,” International Journal of Cardiology, vol. 151, no. 2, pp. 205–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. F. De Oliveira, R. C. Pedrosa, J. H. M. Nascimento, A. C. Campos De Carvalho, and M. O. Masuda, “Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts,” Circulation, vol. 96, no. 6, pp. 2031–2037, 1997. View at Google Scholar · View at Scopus
  47. T. S. McCormick and E. C. Rowland, “Trypanosoma cruzi: cross-reactive anti-heart autoantibodies produced during infection in mice,” Experimental Parasitology, vol. 69, no. 4, pp. 393–401, 1989. View at Google Scholar · View at Scopus
  48. J. C. Goin, C. P. Leiros, E. Borda, and L. Sterin-Borda, “Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications,” FASEB Journal, vol. 11, no. 1, pp. 77–83, 1997. View at Google Scholar · View at Scopus
  49. F. C. Retondaro, P. C. Dos Santos Costa, R. C. Pedrosa, and E. Kurtenbach, “Presence of antibodies against the third intracellular loop of the m2 muscarinic receptor in the sera of chronic chagasic patients,” FASEB Journal, vol. 13, no. 14, pp. 2015–2020, 1999. View at Google Scholar · View at Scopus
  50. J. C. Goin, E. Borda, C. P. Leiros, R. Storino, and L. Sterin-Borda, “Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications,” Journal of the Autonomic Nervous System, vol. 47, no. 1-2, pp. 45–52, 1994. View at Google Scholar · View at Scopus
  51. J. C. Goin, E. S. Borda, S. Auger, R. Storino, and L. Sterin-Borda, “Cardiac M2 muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia,” Heart, vol. 82, no. 3, pp. 273–278, 1999. View at Google Scholar · View at Scopus
  52. A.L.P. Ribeiro, L.E.D. Gimenez, C.C.Q. Hernandez et al., “Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease,” International Journal of Cardiology, vol. 117, no. 1, pp. 59–63, 2007. View at Publisher · View at Google Scholar
  53. L. Sterin-Borda and E. Borda, “Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia,” Annals of the New York Academy of Sciences, vol. 917, pp. 273–280, 2000. View at Google Scholar · View at Scopus
  54. A. Talvani, M. O. C. Rocha, A. L. Ribeiro, E. Borda, L. Sterin-Borda, and M. M. Teixeira, “Levels of anti-M2 and anti-β1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease,” Microbes and Infection, vol. 8, no. 9-10, pp. 2459–2464, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. L. A. P. R. de Resende, R. J. Molina, B. D. C. Ferreira et al., “Cardiac autonomic function in chagasic elderly patients in an endemic area: a time and frequency domain analysis approach,” Autonomic Neuroscience, vol. 131, no. 1-2, pp. 94–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. L. V. Decourt, E. A. Sosa, and F. Pileggi, “Electrophysiologic studies of the heart in the indeterminate form of Chagas' disease,” Arquivos Brasileiros de Cardiologia, vol. 36, no. 4, pp. 227–234, 1981. View at Google Scholar · View at Scopus
  57. L. F. Junqueira Jr and J. D. Soares, “Impaired autonomic control of heart interval changes to Valsalva manoeuvre in Chagas' disease without overt manifestation,” Autonomic Neuroscience, vol. 97, no. 1, pp. 59–67, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. D. Correia, L. F. Junqueira Jr, R. J. Molina, and A. Prata, “Cardiac autonomic modulation evaluated by heart interval variability is unaltered but subtly widespread in the indeterminate Chagas' disease,” Pacing and Clinical Electrophysiology, vol. 30, no. 6, pp. 772–780, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Guzzetti, D. Iosa, M. Pecis, L. Bonura, M. Prosdocimi, and A. Malliani, “Impaired heart rate variability in patients with chronic Chagas' disease,” American Heart Journal, vol. 121, no. 6, pp. 1727–1734, 1991. View at Publisher · View at Google Scholar · View at Scopus
  60. D. F. Vasconcelos and L. F. Junqueira Jr, “Distinctive impaired cardiac autonomic modulation of heart rate variability in chronic Chagas' indeterminate and heart diseases,” Journal of Electrocardiology, vol. 42, no. 3, pp. 281–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. C. C. Hernandez, J. H. Nascimento, E. A. Chaves et al., “Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease,” Journal of Receptors and Signal Transduction Research, vol. 28, no. 4, pp. 375–401, 2008. View at Google Scholar
  62. P. R. Benchimol-Barbosa, “Comments on the letter by Ribeiro et al: impairment of parasympathetic-mediated autonomic modulation of the heart in Chagas's cardiomyopathy: parasympathetic modulation vs tonus,” International Journal of Cardiology, vol. 133, no. 1, pp. 268–270, 2009. View at Google Scholar
  63. D. F. Dávila, J. J. Santiago, and W. Odreman, “Vagal dysfunction and the pathogenesis of chronic Chagas disease,” Int J Cardiol, vol. 103, no. 2, pp. 227–229, 2005. View at Google Scholar
  64. D. F. Dávila, J. H. Donis, L. A. Dávila, W. A. Odreman, G. A. de Bellabarba, and V. Villarroel, “Anti-muscarinic autoantibodies and vagal modulation in Chagas disease: positive allosteric modulators vs desensitization and downregulation of M2 cardiac acetylcholine receptors,” International Journal of Cardiology, vol. 123, no. 3, pp. 328–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. A. L. P. Ribeiro, A. C. Campos de Carvalho, M. Martins Teixeira, F. Lombardi, and M. O. Costa Rocha, “Chagas disease: impaired vagal modulation has been demonstrated, enhanced parasympathetic activity remains to be proved,” International Journal of Cardiology, vol. 123, no. 3, pp. 330–332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Peraza-Cruces, L. Gutiérrez-Guédez, D. Castañeda Perozo, C. R. Lankford, C. Rodríguez-Bonfante, and R. Bonfante-Cabarcas, “Trypanosoma cruzi infection induces up-regulation of cardiac muscarinic acetylcholine receptors in vivo and in vitro,” Brazilian Journal of Medical and Biological Research, vol. 41, no. 9, pp. 796–803, 2008. View at Google Scholar · View at Scopus
  67. L. F. Junqueira Junior Jr, “Insights into the clinical and functional significance of cardiac autonomic dysfunction in Chagas disease,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 45, no. 2, pp. 243–252, 2012. View at Publisher · View at Google Scholar